Phase 1 Parkinson Disease Clinical Trials
29 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–20 of 29 trials
Recruiting
Phase 1
Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Parkinson's Disease
Parkinson Disease (PD)
Royan Institute6 enrolled3 locationsNCT07572071
Recruiting
Phase 1
Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease
PARKINSON DISEASE (Disorder)
University of Alabama at Birmingham24 enrolled1 locationNCT07557706
Recruiting
Phase 1
SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
PARKINSON DISEASE (Disorder)Advanced Parkinson's Disease
Serina Therapeutics40 enrolled6 locationsNCT07422675
Recruiting
Phase 1Phase 2
This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.
Parkinson Disease
iRegene Therapeutics Co., Ltd.5 enrolled1 locationNCT07102342
Recruiting
Phase 1Phase 2
The University of Alabama at Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy
Parkinson Disease
University of Alabama at Birmingham205 enrolled1 locationNCT03457493
Recruiting
Phase 1
Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients
Parkinson DiseaseParkinson's Disease
Innopeutics Corporation6 enrolled1 locationNCT07371338
Recruiting
Phase 1
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Parkinson Disease
Eli Lilly and Company127 enrolled14 locationsNCT06809400
Recruiting
Phase 1
A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease
Parkinson Disease
University of Michigan5 enrolled1 locationNCT07543861
Recruiting
Phase 1
First-in-Human Single and Multiple Dose of HL-400
Parkinson Disease
Highlightll Pharmaceutical (USA) LLC86 enrolled1 locationNCT06997484
Recruiting
Phase 1
Treating Parkinson's Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons
Parkinson Disease
Jeffrey S. Schweitzer, MD, PhD8 enrolled1 locationNCT06687837
Recruiting
Phase 1
[18F]F-DOPA Imaging in Patients With Autonomic Failure
Multiple System AtrophyParkinson DiseaseDementia With Lewy Bodies+2 more
Daniel Claassen40 enrolled1 locationNCT04246437
Recruiting
Phase 1Phase 2
Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy
SafetyPARKINSON DISEASE (Disorder)Apathy
Integrative Research Laboratories AB75 enrolled13 locationsNCT07461220
Recruiting
Phase 1Phase 2
Feasibility Study Assessing the Effect of Carbidopa/Levodopa Ratio on Orthostatic Hypotension in Multiple System Atrophy - Parkinsonian Type and Parkinson Disease.
Parkinson DiseaseOrthostatic Hypotension, DysautonomicMulti-system Atrophy - Parkinsonian Type
Julien Bally36 enrolled2 locationsNCT06831500
Recruiting
Phase 1Phase 2
Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms
PARKINSON DISEASE (Disorder)
U: The Mind Company30 enrolled1 locationNCT07182058
Recruiting
Phase 1Phase 2
Clinical Study to Evaluate XS411 in Treatment of Early-onset Parkinson's Disease
Parkinson Disease (PD)
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.90 enrolled1 locationNCT07166757
Recruiting
Phase 1Phase 2
Celecoxib in Parkinson Disease as Adjuvant Therapy
Parkinson Disease
Tanta University80 enrolled1 locationNCT07246278
Recruiting
Phase 1Phase 2
Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
Parkinson DiseaseParkinson Disease Dementia
Prabesh Kanel45 enrolled1 locationNCT07154511
Recruiting
Phase 1Phase 2
Evaluation of Long-term Safety in Parkinsonian Patients With Intracerebroventricular Administration of A-dopamine (Anaerobic Dopamine)
Parkinson Disease
University Hospital, Lille1 enrolled1 locationNCT07214285
Recruiting
Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
Multiple System AtrophyParkinson DiseaseAutonomic Failure+2 more
Vanderbilt University Medical Center34 enrolled1 locationNCT02897063
Recruiting
Phase 1
Testing if PDR-001 Can Safely and Effectively Remove Harmful Brain Protein in Parkinson's Disease
Parkinson Disease (PD)
Ruijin Hospital12 enrolled1 locationNCT07157345